2m 2m 2m 2m 2m 2m 2m
Insmed (INSM)
NASDAQ
$108.57-$0.58 (-0.53%)
Price as of Jul 13, 2026 7:46 PM EDT- $25.1BMarket Cap
- 7.12%1-Year Change
- BiotechnologyIndustry
Insmed (INSM)
$108.57-$0.58 (-0.53%)
INSM | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $109.14 | ||
Change | -$6.47 (-5.60%) | ||
Open | $114.25 | ||
High | $115.55 | ||
Low | $108.02 | ||
Previous Close | $115.61 | ||
Volume | 2,825,241 | ||
30-Day Average Volume | 4,383,112 | ||
1-Week Change | -2.15% | ||
1-Month Change | 11.54% | ||
1-Year Change | 7.12% | ||
3-Year Change | 420.46% | ||
5-Year Change | 282.81% | ||
Fundamentals | |||
Shares Outstanding | 216.8M | ||
Total Assets | $2.1B | ||
Market Cap | $25.1B | ||
Enterprise Value | $25.0B | ||
Period: QTR TTM FY | |||
Revenue | $306.0M | ||
Net Income | -$163.6M | ||
Free Cash Flow | -$226.2M | ||
EBIT | -$162.1M | ||
EBITDA | -$160.0M | ||
Net Working Capital | $1.3B | ||
EPS | -$0.76 | ||
Enterprise Value/EBITDA | -156 | ||
Enterprise Value/Revenue | 82 | ||
P/B | 36 | ||
P/E | -152 | ||
PEG | -3 | ||
Price/Free Cash Flow | -111 | ||
Price/Operating Cash Flow | -113 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 03/03/2011 | ||
Earnings & Revenue